These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18935765)

  • 1. [Assessment of health related quality of life--Part 1--Direct measures].
    Horowitz E; Hassidim H; Abadi-Korek I; Shemer J
    Harefuah; 2008; 147(8-9):731-4, 748. PubMed ID: 18935765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health values of adolescents with cystic fibrosis.
    Yi MS; Britto MT; Wilmott RW; Kotagal UR; Eckman MH; Nielson DW; Kociela VL; Tsevat J
    J Pediatr; 2003 Feb; 142(2):133-40. PubMed ID: 12584533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preference-based quality of life measures in people with visual impairment.
    Kymes SM; Lee BS
    Optom Vis Sci; 2007 Aug; 84(8):809-16. PubMed ID: 17700344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health related utility measurement: an introduction.
    Bakker C; van der Linden S
    J Rheumatol; 1995 Jun; 22(6):1197-9. PubMed ID: 7674256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality-adjusted life years.
    Bravo Vergel Y; Sculpher M
    Pract Neurol; 2008 Jun; 8(3):175-82. PubMed ID: 18502950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health related quality of life in genital herpes: a pilot comparison of measures.
    Fisman DN
    Sex Transm Infect; 2005 Jun; 81(3):267-70. PubMed ID: 15923300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life: an outcomes perspective.
    Kaplan RM
    Arch Phys Med Rehabil; 2002 Dec; 83(12 Suppl 2):S44-50. PubMed ID: 12474171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods and issues associated with the use of quality-adjusted life-years.
    Revicki DA; Lenderking WR
    Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):105-14. PubMed ID: 22280200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of health related quality of life--part 3--preference based measures].
    Horowitz E; Hassidim H; Abadi-Korek I; Shemer J
    Harefuah; 2008 Nov; 147(11):914-9, 938. PubMed ID: 19264015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The standard gamble method: what is being measured and how it is interpreted.
    Gafni A
    Health Serv Res; 1994 Jun; 29(2):207-24. PubMed ID: 8005790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of subjective life expectancy on health state valuations using a 10 year TTO.
    van Nooten FE; Koolman X; Brouwer WB
    Health Econ; 2009 May; 18(5):549-58. PubMed ID: 18702082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing treatment outcomes using utility assessment for health-related quality of life.
    Kattan MW
    Oncology (Williston Park); 2003 Dec; 17(12):1687-93; discussion 1693-4, 1697, 1701. PubMed ID: 14723008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gap effect: discontinuities of preferences around dead.
    Stalmeier PF; Busschbach JJ; Lamers LM; Krabbe PF
    Health Econ; 2005 Jul; 14(7):679-85. PubMed ID: 15744750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring utilities of severe facial disfigurement and composite tissue allotransplantation of the face in patients with severe face and neck burns from the perspectives of the general public, medical experts and patients.
    Chuback J; Yarascavitch B; Yarascavitch A; Kaur MN; Martin S; Thoma A
    Burns; 2015 Nov; 41(7):1524-31. PubMed ID: 26068209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life utilities for pelvic inflammatory disease health states.
    Smith KJ; Tsevat J; Ness RB; Wiesenfeld HC; Roberts MS
    Sex Transm Dis; 2008 Mar; 35(3):307-11. PubMed ID: 18032995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life after stroke: review of the literature and implications for future research.
    Tseng MC; Lin HJ
    Acta Neurol Taiwan; 2007 Mar; 16(1):7-12. PubMed ID: 17486727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correcting biases in standard gamble and time tradeoff utilities.
    van Osch SM; Wakker PP; van den Hout WB; Stiggelbout AM
    Med Decis Making; 2004; 24(5):511-7. PubMed ID: 15359000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new explanation for the difference between time trade-off utilities and standard gamble utilities.
    Bleichrodt H
    Health Econ; 2002 Jul; 11(5):447-56. PubMed ID: 12112493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-method approach to measuring health-state valuations.
    Salomon JA; Murray CJ
    Health Econ; 2004 Mar; 13(3):281-90. PubMed ID: 14981652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating feelings related to the uncertainty about future health in utility measurement.
    Gandjour A
    Health Econ; 2008 Oct; 17(10):1207-13. PubMed ID: 18074407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.